AstraZeneca Pharma India Limited has informed regarding Disclosure of material issue
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AstraZeneca Pharma India has disclosed that NSE Sustainability Ratings & Analytics Limited assigned it an ESG score of 67 for financial year 2024. The rating was based on publicly available information and was prepared independently — the company did not request or engage NSE Sustainability for this assessment. The report was received on July 8, 2025, and the company filed this disclosure with the exchanges on July 11, 2025, as required under SEBI's Listing Regulations. This is a routine regulatory compliance filing related to sustainability ratings, not a company-initiated evaluation.
An ESG score of 67 indicates a moderate-to-good sustainability profile, which is broadly positive for institutional investors who factor ESG metrics into their decisions. However, since the company did not commission the rating, this is largely a neutral disclosure with limited direct impact on stock price or operations.